Stockscreener 앱 받기
25.58
2.96%
-0.78
시간 외 거래:
25.58
전일 마감가:
$26.36
열려 있는:
$26.46
하루 거래량:
872.19K
Relative Volume:
1.70
시가총액:
$1.25B
수익:
$96.21M
순이익/손실:
$-12.13M
주가수익비율:
-81.73
EPS:
-0.313
순현금흐름:
$10.64M
1주 성능:
-4.05%
1개월 성능:
+23.22%
6개월 성능:
+2.28%
1년 성능:
+17.66%
1일 변동 폭
$25.36
$27.40
1주일 범위
$25.36
$27.70
52주 변동 폭
$17.86
$29.62
바이오라이프 솔루션즈 Stock (BLFS) Company Profile
명칭
Biolife Solutions Inc
전화
(425) 401-1400
주소
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
25.58 | 1.30B | 96.21M | -12.13M | 10.64M | -0.313 |
ISRG
Intuitive Surgical Inc
|
402.18 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
141.61 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.14 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.42 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
186.29 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
바이오라이프 솔루션즈 Stock (BLFS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2024-09-30 | 개시 | H.C. Wainwright | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-11 | 개시 | Craig Hallum | Buy |
| 2022-04-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-19 | 개시 | B. Riley Securities | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-05-14 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-03-23 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-18 | 개시 | Cowen | Outperform |
| 2020-08-11 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-07-08 | 재확인 | Maxim Group | Buy |
| 2020-02-24 | 개시 | Lake Street | Buy |
| 2020-02-19 | 개시 | The Benchmark Company | Buy |
| 2020-02-06 | 재개 | B. Riley FBR | Buy |
| 2020-01-08 | 개시 | Stephens | Overweight |
| 2019-11-21 | 개시 | Oppenheimer | Outperform |
| 2019-07-22 | 개시 | H.C. Wainwright | Buy |
| 2017-11-10 | 재확인 | Maxim Group | Buy |
| 2017-09-19 | 재확인 | Maxim Group | Buy |
| 2017-07-05 | 업그레이드 | Janney | Neutral → Buy |
| 2017-03-10 | 재확인 | Maxim Group | Buy |
| 2017-01-19 | 개시 | Maxim Group | Buy |
모두보기
바이오라이프 솔루션즈 주식(BLFS)의 최신 뉴스
(BLFS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
BioLife Solutions, Inc. (BLFS) tops Q1 earnings and revenue estimates - MSN
BioLife Solutions (BLFS) CFO reports 1,026-share tax withholding, retains 215,030 - Stock Titan
[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity - Stock Titan
BIOLIFE SOLUTIONS (BLFS) EVP has 627 shares withheld to cover RSU taxes - Stock Titan
BioLife Solutions (BLFS) Gains 1.5% as Stock Tests Key Resistance LevelFibonacci Retracement - newsline.com
BioLife Solutions Shares Edge Lower On Latest SEC Disclosures - Bez Kabli
[SCHEDULE 13G] BIOLIFE SOLUTIONS INC Passive Investment Disclosure (>5%) - Stock Titan
BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair Value - Yahoo Finance
BioLife Highlights Strategy Shift in New Investor Presentation - TipRanks
BioLife Solutions issues investor presentation, cites $96M FY2025 revenue and 17-20% 2026 guidance - TradingView
BioLife Solutions (NASDAQ: BLFS) guides to 17–20% revenue growth and GAAP profitability in 2026 - Stock Titan
HC Wainwright Has Pessimistic Outlook of BLFS Q2 Earnings - MarketBeat
Utah Medical gains 32% in a year: Should you buy the stock? - MSN
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Life science company planning relocation to Noblesville with nearly 40,000-square-foot facility - MSN
Activist Interest Puts Spotlight On BioLife Solutions Valuation And Momentum - Sahm
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and BioLife Solutions (BLFS) - The Globe and Mail
BioLife Solutions Inc (BLFS) Stock Up 3.1% and Still Undervalued -- GF Score: 73/100 - GuruFocus
BioLife : Register Now for The Cell Summit ’26 - marketscreener.com
BioLife Solutions coming to Noblesville - Current Publishing
Life sciences firm planning $16M relocation to Noblesville - Inside INdiana Business
BioLife Solutions (BLFS) Gains Ground: Moving Toward Key Resistance at $25.73Volume Profile - newsline.com
BioLife Solutions (BLFS) Dips 1.38%: Support Test LoomsCharm Flow - newsline.com
BioLife Solutions Q1 2026 Earnings: EPS Slightly Misses Estimates, Stock DeclinesReturn On Assets - The Legal Advocate
Trading Systems Reacting to (BLFS) Volatility - Stock Traders Daily
Casdin discloses 9.7% BioLife Solutions stake (NASDAQ: BLFS) - Stock Titan
Casdin Capital, Eli Casdin sell $28.1m in NASDAQ:BLFS stock By Investing.com - Investing.com South Africa
BioLife Solutions (BLFS) Faces Headwinds: Shares Decline 3.19% to $23.95ADD Alert - newsline.com
BioLife Solutions Inc (BLFS) Shares Surge 3.0% -- What GF Score of 73 Tells Investors - GuruFocus
BioLife Solutions(BLFS.US) 10% Shareholder Sells US$28.13 Million in Common Stock - Moomoo
Casdin Partners (NASDAQ: BLFS) files Form 144 for 650,000-share resale notice - Stock Titan
Summit Creek Advisors LLC Grows Stock Holdings in BioLife Solutions, Inc. $BLFS - MarketBeat
Why BioLife Solutions (BLFS) Is Up 13.4% After Q1 Return To Profitability And Reaffirmed Outlook - simplywall.st
BLFS (NASDAQ) affiliate notifies sale of 250,000 shares via BMO Capital Markets - Stock Titan
BioLife (NASDAQ: BLFS) proposed sale of 300,000 shares, $6.69M listed - Stock Titan
Wall Street analysts think BioLife Solutions (BLFS) could surge 70.78%: Read this before placing a bet - MSN
Number of shareholders of BioLife Solutions, Inc. – NASDAQ:BLFS - TradingView
Number of shareholders of BioLife Solutions, Inc. – DUS:BJX1 - TradingView
T. Rowe Price (BLFS) reports 6.51M shares, 13.5% stake disclosed - Stock Titan
BLFS Stock Price, Quote & Chart | BIOLIFE SOLUTIONS INC (NASDAQ:BLFS) - ChartMill
BLFS: BioLife SolutionsInteractive Chart - Zacks Investment Research
Biolife outlines 2026 revenue of $112.5M-$115M while targeting full-year GAAP net income - MSN
How Biolife Solutions Inc. (BLFS) Affects Rotational Strategy Timing - Stock Traders Daily
A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum - Yahoo Finance
Lake Street Sticks to Their Buy Rating for BioLife Solutions (BLFS) - The Globe and Mail
BioLife Solutions (NASDAQ:BLFS) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
BioLife Solutions Earnings Call Highlights Growth Path - TipRanks
BioLife Solutions, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
BioLife Solutions Q1 2026 Earnings Call Transcript - MarketBeat
BioLife (BLFS) smashes Q1 estimates with 96% EPS surprise, driving 6.3% stock jump.Quarterly Earnings - newsline.com
바이오라이프 솔루션즈 (BLFS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
바이오라이프 솔루션즈 주식 (BLFS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | 10% Owner |
May 19 '26 |
Sale |
22.65 |
300,000 |
6,795,000 |
5,657,165 |
| Casdin Partners Master Fund, L | 10% Owner |
May 20 '26 |
Sale |
23.70 |
250,000 |
5,925,000 |
5,407,165 |
5.23%
자본화:
|
볼륨(24시간):